Pure Global
NCT05956652

Hydra Registry - Italy Experience

Observational Study on the Efficacy and Safety of Transcatheter Implantation of Hydra Biological Aortic Prosthesis
Sahajanand Medical Technologies Limited·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Aortic Valve Stenosis
Drug/Device/Intervention
Hydra Transcatheter Aortic Valve System
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Sahajanand Medical Technologies Limited
Location
Brescia,Mercogliano,Milano,Padova, Italy
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2023
End date
Jul 31, 2029
Enrollment
500 participants
Primary outcome

Cardiovascular mortality

Summary

Hydra-IT is a multicenter observational study aim to collect clinical, procedural and
 follow-up data and evaluate the short, medium and long term results of Hydra TAVI System in
 patient with severe aortic stenosis.

ICD-10 classifications
Aortic (valve) stenosisAortic (valve) stenosis with insufficiencyCongenital stenosis of aortic valveStenosis of aortaRheumatic aortic stenosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05956652
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05956652 through Pure Global AI's free database. This phase not specified trial is sponsored by Sahajanand Medical Technologies Limited and is currently Recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.